MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Eikon Therapeutics, Inc. (EIKN)

Eikon Therapeutics, Inc. (EIKN)

|||

Balance Sheets Overview

Current Ratio
989.18%
Quick Ratio
989.18%
Cash Ratio
257.91%
Debt to Asset Ratio
40.16%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities
    • Cash and cash equivalents
    • Operating lease right-of-use ass...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Operating lease liability, non-c...
    • Others
Balance Sheets
2026-06-30
2026-03-31
Cash and cash equivalents
142,613
161,154
Marketable securities
388,565
351,028
Prepaid expenses and other current assets
15,400
16,919
Restricted cash, current
400
400
Total current assets
546,978
529,501
Property and equipment, gross
186,285
186,161
Less accumulated depreciation
53,214
48,094
Property and equipment, net
133,071
138,067
Operating lease right-of-use assets
91,137
91,066
Marketable securities, non-current
-
83,828
Restricted cash, non-current
7,845
7,808
Other non-current assets
539
556
Total assets
779,570
850,826
Accounts payable
6,564
6,005
Accrued expenses and other current liabilities
39,287
29,319
Operating lease liability, current
9,445
9,740
Total current liabilities
55,296
45,064
Operating lease liability, non-current
242,774
245,091
Other non-current liabilities
15,000
10,000
Total liabilities
313,070
300,155
Common stock, 0.0001 par value 500,000,000 shares authorized and 54,148,887 shares issued and outstanding as of june 30, 2026 and 340,650,000 shares authorized and 3,068,490 shares issued and outstanding as of december 31, 2025
5
5
Additional paid-in capital
1,558,371
1,554,133
Accumulated deficit
-1,091,876
-1,003,467
Total stockholders' equity (deficit)
466,500
550,671
Total liabilities, redeemable convertible preferred stock, and stockholders' equity (deficit)
779,570
850,826
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$388,565K Cash and cashequivalents$142,613K Prepaid expenses andother current assets$15,400K Restricted cash, current$400K Property and equipment,gross$186,285K Total current assets$546,978K Property and equipment,net$133,071K Operating leaseright-of-use assets$91,137K Restricted cash,non-current$7,845K Other non-currentassets$539K Less accumulateddepreciation$53,214K Total assets$779,570K Total liabilities,redeemable convertible...$779,570K Total stockholders'equity (deficit)$466,500K Total liabilities$313,070K Accumulated deficit-$1,091,876K Additional paid-in capital$1,558,371K Operating leaseliability, non-current$242,774K Total currentliabilities$55,296K Other non-currentliabilities$15,000K Common stock, 0.0001par value...$5K Accrued expenses andother current...$39,287K Operating leaseliability, current$9,445K Accounts payable$6,564K